Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Santer

Showing results (81-90 of 110) with videos related to

Pageof 11
Sort By:
The American Journal of Pathology|March 11, 2021
MYC-Mediated Ribosomal Gene Expression Sensitizes Enzalutamide-resistant Prostate Cancer Cells to EP300/CREBBP InhibitorsTobias Furlan, Alexander Kirchmair, Natalie Sampson, et al.
Clinical Genetics|June 2, 2007
Glucose metabolism and insulin secretion in a patient with ABCC8 mutation and Fanconi-Bickel syndrome caused by maternal isodisomy of chromosome 3T L Hoffman, E Blanco, A Lane, et al.
American Journal of Human Genetics|June 23, 2026
Homologous recombination deficiency-driven genomic instability in ovarian cancer as an indicator of BRCA1 and BRCA2 variant pathogenicitySimon Schnaiter, Frédéric R Santer, Katalin A Csanaky, et al.
Endocrine-Related Cancer|January 18, 2020
p300 is upregulated by docetaxel and is a target in chemoresistant prostate cancerMartina Gruber, Lavinia Ferrone, Martin Puhr, et al.
European Journal of Human Genetics : EJHG|May 30, 2001
Molecular genetic basis and prevalence of glycogen storage disease type IIIA in the Faroe IslandsR Santer, M Kinner, U Steuerwald, et al.
Journal of Inherited Metabolic Disease|September 10, 2005
A new fluorimetric enzyme assay for the diagnosis of Niemann-Pick A/B, with specificity of natural sphingomyelinase substrateO P van Diggelen, Ya V Voznyi, J L M Keulemans, et al.
Endocrine-Related Cancer|June 4, 2016
The AR/NCOA1 axis regulates prostate cancer migration by involvement of PRKD1Birgit Luef, Florian Handle, Gvantsa Kharaishvili, et al.
Molecular Oncology|March 19, 2016
DNA damage signalling barrier, oxidative stress and treatment-relevant DNA repair factor alterations during progression of human prostate cancerDaniela Kurfurstova, Jirina Bartkova, Radek Vrtel, et al.
The American Journal of Pathology|April 4, 2009
Suppressor of cytokine signaling (SOCS)-1 is expressed in human prostate cancer and exerts growth-inhibitory function through down-regulation of cyclins and cyclin-dependent kinasesHannes Neuwirt, Martin Puhr, Frédéric R Santer, et al.
International Journal of Cancer|April 27, 2018
Oncolytic activity of the rhabdovirus VSV-GP against prostate cancerCarles Urbiola, Frédéric R Santer, Monika Petersson, et al.
Pageof 11

Showing results (81-90 of 110) with videos related to

Sort By:
Pageof 11
The American Journal of Pathology|March 11, 2021
MYC-Mediated Ribosomal Gene Expression Sensitizes Enzalutamide-resistant Prostate Cancer Cells to EP300/CREBBP InhibitorsTobias Furlan, Alexander Kirchmair, Natalie Sampson, et al.
Clinical Genetics|June 2, 2007
Glucose metabolism and insulin secretion in a patient with ABCC8 mutation and Fanconi-Bickel syndrome caused by maternal isodisomy of chromosome 3T L Hoffman, E Blanco, A Lane, et al.
American Journal of Human Genetics|June 23, 2026
Homologous recombination deficiency-driven genomic instability in ovarian cancer as an indicator of BRCA1 and BRCA2 variant pathogenicitySimon Schnaiter, Frédéric R Santer, Katalin A Csanaky, et al.
Endocrine-Related Cancer|January 18, 2020
p300 is upregulated by docetaxel and is a target in chemoresistant prostate cancerMartina Gruber, Lavinia Ferrone, Martin Puhr, et al.
European Journal of Human Genetics : EJHG|May 30, 2001
Molecular genetic basis and prevalence of glycogen storage disease type IIIA in the Faroe IslandsR Santer, M Kinner, U Steuerwald, et al.
Journal of Inherited Metabolic Disease|September 10, 2005
A new fluorimetric enzyme assay for the diagnosis of Niemann-Pick A/B, with specificity of natural sphingomyelinase substrateO P van Diggelen, Ya V Voznyi, J L M Keulemans, et al.
Endocrine-Related Cancer|June 4, 2016
The AR/NCOA1 axis regulates prostate cancer migration by involvement of PRKD1Birgit Luef, Florian Handle, Gvantsa Kharaishvili, et al.
Molecular Oncology|March 19, 2016
DNA damage signalling barrier, oxidative stress and treatment-relevant DNA repair factor alterations during progression of human prostate cancerDaniela Kurfurstova, Jirina Bartkova, Radek Vrtel, et al.
The American Journal of Pathology|April 4, 2009
Suppressor of cytokine signaling (SOCS)-1 is expressed in human prostate cancer and exerts growth-inhibitory function through down-regulation of cyclins and cyclin-dependent kinasesHannes Neuwirt, Martin Puhr, Frédéric R Santer, et al.
International Journal of Cancer|April 27, 2018
Oncolytic activity of the rhabdovirus VSV-GP against prostate cancerCarles Urbiola, Frédéric R Santer, Monika Petersson, et al.
Pageof 11